Literature DB >> 17359283

Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells.

Naofumi Kagara1, Natsumi Tanaka, Shinzaburo Noguchi, Toshio Hirano.   

Abstract

Zinc is an essential element, necessary for sustaining all life. Zinc deficiency causes taste impairments, immune deficiency, skin problems, and growth and mental retardation. Recent reports suggest that zinc is associated with an increased risk of cancer, although it is still unclear whether zinc or its transporters are involved in cancer progression. Here we show that zinc and its transporter ZIP10 are involved in the invasive behavior of breast cancer cells. The screening of clinical samples for ZIP10 mRNA expression suggested that ZIP10 was significantly associated with the metastasis of breast cancer to the lymph node. In addition, the expression of ZIP10 mRNA was higher in the invasive and metastatic breast cancer cell lines MDA-MB-231 and MDA-MB-435S than in less metastatic breast cancer cell lines, such as MCF7, T47D, ZR75-1 and ZR75-30. In in vitro cell migration assays, the depletion of zinc transporter ZIP10 and intracellular zinc inhibited the migratory activity of MDA-MB-231 and MDA-MB-435S cells. These results showed that zinc and ZIP10 play an essential role in the migratory activity of highly metastatic breast cancer cells, and suggest ZIP10 as a possible marker for the metastatic phenotype of breast cancer and a promising target of novel treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359283     DOI: 10.1111/j.1349-7006.2007.00446.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  78 in total

Review 1.  Novel metals and metal complexes as platforms for cancer therapy.

Authors:  Michael Frezza; Sarmad Hindo; Di Chen; Andrew Davenport; Sara Schmitt; Dajena Tomco; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Mammary gland zinc metabolism: regulation and dysregulation.

Authors:  Shannon L Kelleher; Young Ah Seo; Veronica Lopez
Journal:  Genes Nutr       Date:  2009-04-02       Impact factor: 5.523

3.  Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.

Authors:  Min Li; Yuqing Zhang; Uddalak Bharadwaj; Qihui Jim Zhai; Charlotte H Ahern; William E Fisher; F Charles Brunicardi; Craig D Logsdon; Changyi Chen; Qizhi Yao
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 4.  Physiological roles of zinc transporters: molecular and genetic importance in zinc homeostasis.

Authors:  Takafumi Hara; Taka-Aki Takeda; Teruhisa Takagishi; Kazuhisa Fukue; Taiho Kambe; Toshiyuki Fukada
Journal:  J Physiol Sci       Date:  2017-01-27       Impact factor: 2.781

5.  A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin.

Authors:  Rebecca Justiniano; Jessica Perer; Anh Hua; Mohammad Fazel; Andrea Krajisnik; Christopher M Cabello; Georg T Wondrak
Journal:  Photochem Photobiol       Date:  2017-07-21       Impact factor: 3.421

6.  Resveratrol-zinc combination for prostate cancer management.

Authors:  Chandra K Singh; Anna Pitschmann; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

7.  ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer.

Authors:  Xiaobo Cui; Yuqing Zhang; Jingxuan Yang; Xiaotian Sun; John P Hagan; Sushovan Guha; Min Li
Journal:  Cell Cycle       Date:  2014-02-11       Impact factor: 4.534

8.  Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration.

Authors:  Benjamin P Weaver; Yuxia Zhang; Stephen Hiscox; Grace L Guo; Udayan Apte; Kathryn M Taylor; Christian T Sheline; Li Wang; Glen K Andrews
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

9.  Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer.

Authors:  J Yang; Y Zhang; X Cui; W Yao; X Yu; P Cen; S E Hodges; W E Fisher; F C Brunicardi; C Chen; Q Yao; M Li
Journal:  Curr Mol Med       Date:  2013-03       Impact factor: 2.222

10.  Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

Authors:  Galatea Kallergi; Harris Markomanolaki; Vicky Giannoukaraki; Maria A Papadaki; Areti Strati; Evi S Lianidou; Vassilis Georgoulias; Dimitris Mavroudis; Sofia Agelaki
Journal:  Breast Cancer Res       Date:  2009-11-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.